The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
The Warburg effect and drug resistance
Open accessAbstract
The Warburg effect describes the increased utilization of glycolysis rather than oxidative phosphorylation by tumour cells for their energy requirements under physiological oxygen conditions. This effect has been the basis for much speculation on the survival advantage of tumour cells, tumourigenesis and the microenvironment of tumours. More recently, studies have begun to reveal how the Warburg effect could influence drug efficacy and how our understanding of tumour energetics could be exploited to improve drug development. In particular, evidence is emerging demonstrating how better modelling of the tumour metabolic microenvironment could lead to a better prediction of drug efficacy and the identification of new combination strategies. This review will provide details of the current understanding of the complex interplay between glucose metabolism and pharmacology and discuss opportunities for utilizing the Warburg effect in future drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sain, N., Krishnan, B., Ormerod, M. G., Rienzo, A. D., Liu, W. M., Kaye, S. B., Workman, P., & Jackman, A. L. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0445 · Cited by 92
RetractedRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Jung, C. H., Ro, S.-H., Cao, J., Otto, N. M., & Kim, D.-H. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.017 · Cited by 2,090
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035972 · Cited by 1,946
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
Shackelford, D. B., & Shaw, R. J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2676 · Cited by 1,943
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., & Thompson, C. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.027 · Cited by 1,619
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR‐1
Lizcano, J. M., Göransson, O., Toth, R., Deak, M., Morrice, N. A., Boudeau, J., Hawley, S. A., Udd, L., Mäkelä, T. P., Hardie, D. G., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600110 · Cited by 1,381
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
Sui, X., Chen, R., Wang, Z., Huang, Z., Kong, N., Zhang, M., Han, W., Lou, F., Yang, J., Zhang, Q., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.350 · Cited by 1,204
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
Jeon, S.-M., Chandel, N. S., & Hay, N. (2012) · Nature · doi:10.1038/nature11066 · Cited by 1,132
Lactate: A Metabolic Key Player in Cancer
Hirschhaeuser, F., Sattler, U. G. A., & Mueller-Klieser, W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1457 · Cited by 1,090
The Biology of Cancer Stem Cells
Lobo, N. A., Shimono, Y., Qian, D., & Clarke, M. F. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104154 · Cited by 1,043
Glucose transporters in the 21st Century
Thorens, B., & Mueckler, M. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00712.2009 · Cited by 1,013
MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
Dang, C. V., Le, A., & Gao, P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0889 · Cited by 946
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
Yun, J., Rago, C., Cheong, I., Pagliarini, R., Angenendt, P., Rajagopalan, H., Schmidt, K., Willson, J. K. V., Markowitz, S., Zhou, S., et al. (2009) · Science · doi:10.1126/science.1174229 · Cited by 914
Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc
Osthus, R. C., Shim, H., Kim, S., Li, Q., Reddy, R., Mukherjee, M., Xu, Y., Wonsey, D., Lee, L. A., & Dang, C. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000023200 · Cited by 879
Liang, J., Shao, S. H., Xu, Z.-X., Hennessy, B., Ding, Z., Larrea, M., Kondo, S., Dumont, D. J., Gutterman, J. U., Walker, C. L., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1537 · Cited by 866
Pawson, A. J., Sharman, J. L., Benson, H. E., Faccenda, E., Alexander, S. P. H., Buneman, O. P., Davenport, A. P., McGrath, J. C., Peters, J. A., Southan, C., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1143 · Cited by 849
Heat Shock Factor 1 Is a Powerful Multifaceted Modifier of Carcinogenesis
Dai, C., Whitesell, L., Rogers, A. B., & Lindquist, S. (2007) · Cell · doi:10.1016/j.cell.2007.07.020 · Cited by 826
Nogueira, V., Park, Y., Chen, C.-C., Xu, P.-Z., Chen, M.-L., Tonic, I., Unterman, T., & Hay, N. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.11.003 · Cited by 780
Mathupala, S. P., Ko, Y. H., & Pedersen, P. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209603 · Cited by 765
Mitochondrial Binding of Hexokinase II Inhibits Bax-induced Cytochrome c Release and Apoptosis
Pastorino, J. G., Shulga, N., & Hoek, J. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109950200 · Cited by 713
Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond
Ganapathy, V., Thangaraju, M., & Prasad, P. D. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.09.005 · Cited by 710
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
Kelloff, G. J., Hoffman, J. M., Johnson, B., Scher, H. I., Siegel, B. A., Cheng, E. Y., Cheson, B. D., O'Shaughnessy, J., Guyton, K. Z., Mankoff, D. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2626 · Cited by 671
Rohwer, N., & Cramer, T. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.03.001 · Cited by 608
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
Alexander, S. P., Fabbro, D., Kelly, E., Marrion, N., Peters, J. A., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13354 · Cited by 604
Discovery of small molecule cancer drugs: Successes, challenges and opportunities
Hoelder, S., Clarke, P. A., & Workman, P. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.02.004 · Cited by 587
Sun, Q., Chen, X., Ma, J., Peng, H., Wang, F., Zha, X., Wang, Y., Jing, Y., Yang, H., Chen, R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014769108 · Cited by 586
Liu, Y., Cao, Y., Zhang, W., Bergmeier, S., Qian, Y., Akbar, H., Colvin, R., Ding, J., Tong, L., Wu, S., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0131 · Cited by 555
A Lactate-Induced Response to Hypoxia
Lee, D. C., Sohn, H. A., Park, Z.-Y., Oh, S., Kang, Y. K., Lee, K.-M., Kang, M., Jang, Y. J., Yang, S.-J., Hong, Y. K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.011 · Cited by 520
Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake
Flavahan, W. A., Wu, Q., Hitomi, M., Rahim, N., Kim, Y., Sloan, A. E., Weil, R. J., Nakano, I., Sarkaria, J. N., Stringer, B. W., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3510 · Cited by 510
Diaz-Ruiz, R., Rigoulet, M., & Devin, A. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.08.010 · Cited by 486
Cancer Stem Cells and Drug Resistance: The Potential of Nanomedicine
Vinogradov, S., & Wei, X. (2012) · Nanomedicine · doi:10.2217/nnm.12.22 · Cited by 474
Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer
Pate, K. T., Stringari, C., Sprowl‐Tanio, S., Wang, K., TeSlaa, T., Hoverter, N. P., McQuade, M. M., Garner, C., Digman, M. A., Teitell, M. A., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201488598 · Cited by 459
Hypoxia inducible factors in cancer stem cells
Heddleston, J. M., Li, Z., Lathia, J. D., Bao, S., Hjelmeland, A. B., & Rich, J. N. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605551 · Cited by 452
Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive Review
Porporato, P. E., Dhup, S., Dadhich, R. K., Copetti, T., & Sonveaux, P. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00049 · Cited by 425
Cancer cell metabolism: implications for therapeutic targets
Jang, M., Kim, S. S., & Lee, J. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.85 · Cited by 397
ERK activation upon hypoxia: involvement in HIF‐1 activation
Minet, E., Arnould, T., Michel, G., Roland, I., Mottet, D., Raes, M., Remacle, J., & Michiels, C. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01181-9 · Cited by 379
Ko, Y. H., Pedersen, P. L., & Geschwind, J. F. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00667-x · Cited by 347
Martinez-Outschoorn, U. E., Prisco, M., Ertel, A., Tsirigos, A., Lin, Z., Pavlides, S., Wang, C., Flomenberg, N., Knudsen, E. S., Howell, A., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.8.15330 · Cited by 338
Glycolysis in cancer: A potential target for therapy
Gatenby, R. A., & Gillies, R. J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.03.021 · Cited by 304
Hu, Y., Lu, W., Chen, G., Wang, P., Chen, Z., Zhou, Y., Ogasawara, M., Trachootham, D., Feng, L., Pelicano, H., et al. (2012) · Cell Research · doi:10.1038/cr.2011.145 · Cited by 304
Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism
Zhao, Y., Liu, H., Liu, Z., Ding, Y., LeDoux, S. P., Wilson, G. L., Voellmy, R., Lin, Y., Lin, W., Nahta, R., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0127 · Cited by 289
Hedgehog Partial Agonism Drives Warburg-like Metabolism in Muscle and Brown Fat
Teperino, R., Amann, S., Bayer, M., McGee, S. L., Loipetzberger, A., Connor, T., Jaeger, C., Kammerer, B., Winter, L., Wiche, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.09.021 · Cited by 283
The Concise Guide to PHARMACOLOGY 2015/16: Transporters
Alexander, S. P., Kelly, E., Marrion, N., Peters, J. A., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J. A., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13355 · Cited by 266
Imatinib (STI571)-Mediated Changes in Glucose Metabolism in Human Leukemia BCR-ABL-Positive Cells
Gottschalk, S., Anderson, N., Hainz, C., Eckhardt, S. G., & Serkova, N. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0039 · Cited by 256
p53 and Metabolism: Inside the TIGAR
Green, D. R., & Chipuk, J. E. (2006) · Cell · doi:10.1016/j.cell.2006.06.032 · Cited by 239
A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression
Buller, C. L., Loberg, R. D., Fan, M.-H., Zhu, Q., Park, J. L., Vesely, E., Inoki, K., Guan, K.-L., & Brosius, F. C. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00554.2007 · Cited by 238
Oxidative phosphorylation in cancer cells
Solaini, G., Sgarbi, G., & Baracca, A. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.09.003 · Cited by 231
The Concise Guide to PHARMACOLOGY 2015/16: Overview
Alexander, S. P., Kelly, E., Marrion, N., Peters, J. A., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., Buneman, O. P., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13347 · Cited by 230
Cao, X., Fang, L., Gibbs, S., Huang, Y., Dai, Z., Wen, P., Zheng, X., Sadee, W., & Sun, D. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0291-9 · Cited by 221
Glucose regulated proteins in cancer progression, Drug resistance and immunotherapy
Fu, Y., & Lee, A. S. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.7.2970 · Cited by 219
Shen, Y.-C., Ou, D.-L., Hsu, C., Lin, K.-L., Chang, C.-Y., Lin, C.-Y., Liu, S.-H., & Cheng, A.-L. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.559 · Cited by 202
Altered states: selectively drugging the Hsp90 cancer chaperone
Workman, P. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.12.005 · Cited by 195
Clarke, P. A., Hostein, I., Banerji, U., Stefano, F. D., Maloney, A., Walton, M., Judson, I., & Workman, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203753 · Cited by 194
Metabolic Stress in Autophagy and Cell Death Pathways
Altman, B. J., & Rathmell, J. C. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008763 · Cited by 193
McBrayer, S. K., Cheng, J. C., Singhal, S., Krett, N. L., Rosen, S. T., & Shanmugam, M. (2012) · Blood · doi:10.1182/blood-2011-09-377846 · Cited by 192
Mathupala, S. P., Ko, Y. H., & Pedersen, P. L. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.03.025 · Cited by 186
Hypoxic Tumor Microenvironment and Cancer Cell Differentiation
Kim, Y., Lin, Q., Glazer, P., & Yun, Z. (2009) · Current Molecular Medicine · doi:10.2174/156652409788167113 · Cited by 183
Pore, N., Jiang, Z., Shu, H.-K., Bernhard, E., Kao, G. D., & Maity, A. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0234 · Cited by 183
Saito, S., Furuno, A., Sakurai, J., Sakamoto, A., Park, H.-R., Shin-ya, K., Tsuruo, T., & Tomida, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2689 · Cited by 160
The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors
Alexander, S. P., Fabbro, D., Kelly, E., Marrion, N., Peters, J. A., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13353 · Cited by 159
A pivotal role for p53: balancing aerobic respiration and glycolysis
Ma, W., Sung, H. J., Park, J., Matoba, S., & Hwang, P. M. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9083-0 · Cited by 155
Geschwind, J.-F. H., Georgiades, C. S., Ko, Y. H., & Pedersen, P. L. (2004) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.4.3.449 · Cited by 141
Autophagy modulation: a target for cancer treatment development
Duffy, A. P., Le, J., Sausville, E. A., & Emadi, A. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2637-z · Cited by 136
Page, T. J., Sikder, D. S., Yang, L., Pluta, L., Wolfinger, R. D., Kodadek, T. J., & Thomas, R. S. (2006) · Molecular BioSystems · doi:10.1039/b606129j · Cited by 129
Calvé, B. L., Rynkowski, M. A., Mercier, M. L., Bruyère, C., Lonez, C., Gras, T., Haibe‐Kains, B., Bontempi, G., Decaestecker, C., Ruysschaert, J., et al. (2010) · Neoplasia · doi:10.1593/neo.10526 · Cited by 126
Role of Oxidative Phosphorylation in Bax Toxicity
Harris, M. H., Heiden, M. G. V., Kron, S. J., & Thompson, C. B. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.10.3590-3596.2000 · Cited by 119
Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice
Shi, H., Li, D., Zhang, J., Wang, Y., Li, Y., Zhang, H., Wang, X., Mu, B., Wang, W., Ma, Y., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01562.x · Cited by 114
From tumor cell metabolism to tumor immune escape
Villalba, M., Rathore, M. G., López-Royuela, N., Krzywińska, E., Garaude, J., & Allende-Vega, N. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.04.024 · Cited by 113
Schneider, A., Younis, R. H., & Gutkind, J. S. (2008) · Neoplasia · doi:10.1593/neo.08586 · Cited by 112
Tomiyama, A., Serizawa, S., Tachibana, K., Sakurada, K., Samejima, H., Kuchino, Y., & Kitanaka, C. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj395 · Cited by 107
Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model
Guo, W., Zhang, Y., Chen, T., Wang, Y., Xue, J., Zhang, Y., Xiao, W., Mo, X., & Lü, Y. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0860-5 · Cited by 99
Morten, K., Badder, L. M., & Knowles, H. J. (2013) · The Journal of Pathology · doi:10.1002/path.4159 · Cited by 92
mTOR as a Positive Regulator of Tumor Cell Responses to Hypoxia
Abraham, R. T. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-18930-2_18 · Cited by 91
Yoo, B. C., Ku, J., Hong, S., Shin, Y., Park, S. Y., Kim, H. K., & Park, J. (2003) · International Journal of Cancer · doi:10.1002/ijc.11604 · Cited by 87
TIGAR Has a Dual Role in Cancer Cell Survival through Regulating Apoptosis and Autophagy
Xie, J., Li, B., Yu, H.-P., Gao, Q.-G., Li, W., Wu, H., & Qin, Z. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3517 · Cited by 85
Bhattacharya, B., Low, S. H. H., Soh, C. K., Mustapa, N. K., Beloueche‐Babari, M., Koh, K. X., Loh, J. Y., & Soong, R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12668 · Cited by 81
Self-citationKwon, O., Kang, T.-W., Kim, J., Kim, S., Noh, S., Song, K., Yoo, H., Kim, W. H., Zhi, X., Pocalyko, D. J., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.063 · Cited by 80
Tesori, V., Piscaglia, A. C., Samengo, D., Barba, M., Bernardini, C., Scatena, R., Pontoglio, A., Castellini, L., Spelbrink, J. N., Maulucci, G., et al. (2015) · Scientific Reports · doi:10.1038/srep09149 · Cited by 80
Inhibition of Glucose Transporter 1 (GLUT1) Chemosensitized Head and Neck Cancer Cells to Cisplatin
Wang, Y., Li, S., & Liao, J.-X. (2013) · Technology in Cancer Research & Treatment · doi:10.7785/tcrt.2012.500343 · Cited by 76
Tumor Metabolism of Malignant Gliomas
Ru, P., Williams, T. M., Chakravarti, A., & Guo, D. (2013) · Cancers · doi:10.3390/cancers5041469 · Cited by 74
Shin, Y., Yoo, B. C., Hong, Y. S., Chang, H. J., Jung, K. H., Jeong, S., & Park, J. (2009) · Electrophoresis · doi:10.1002/elps.200800806 · Cited by 71
The metabolic cooperation between cells in solid cancer tumors.
Icard, P., Kafara, P., Steyaert, J.-M., Schwartz, L., & Lincet, H. (2014) · Biochimica et Biophysica Acta · doi:10.1016/j.bbcan.2014.06.002 · Cited by 71
Functional Activation of Heat Shock Factor and Hypoxia-Inducible Factor in the Kidney
Eickelberg, O., Seebach, F. A., Riordan, M., Thulin, G., Mann, A., Reidy, K. H., Why, S. K. V., Kashgarian, M. J., & Siegel, N. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000022008.30175.5b · Cited by 67
GLUT1 enhances mTOR activity independently of TSC2 and AMPK
Buller, C. L., Heilig, C. W., & Brosius, F. C. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00472.2010 · Cited by 67
Effects of the HIV Protease Inhibitor Ritonavir on GLUT4 Knock-out Mice
Vyas, A. K., Koster, J. C., Tzekov, A., & Hruz, P. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.176321 · Cited by 66
Martinez‐Balibrea, E., Plasencia, C., Ginés, A., Martínez‐Cardús, A., Musulén, E., Aguilera, R., Manzano, J. L., Neamati, N., & Abad, A. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0882 · Cited by 63
Marignac, V. L. M., Smith, S. E., Toban, N., Bazile, M., & Aloyz, R. S. (2013) · Oncotarget · doi:10.18632/oncotarget.1508 · Cited by 59
Physiological glucose is critical for optimized neuronal viability and AMPK responsiveness in vitro
Kleman, A. M., Yuan, J., Aja, S. M., Ronnett, G. V., & Landree, L. E. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.08.028 · Cited by 58
ERK and Calcium in Activation of HIF‐1
Mottet, D., Michel, G., Renard, P., Ninane, N., Raes, M. J., & Michiels, C. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04681.x · Cited by 58
Onozuka, H., Tsuchihara, K., & Esumi, H. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01880.x · Cited by 55
Nihira, K., Miki, Y., Iida, S., Narumi, S., Ono, K., Iwabuchi, E., Ise, K., Mori, K., Saito, M., Ebina, M., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4354 · Cited by 52
Min, J. W., Kim, K. I., Kim, H., Kim, E., Noh, W. C., Jeon, H. B., Cho, D., Oh, J. S., Park, I., Hwang, S., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.09.041 · Cited by 50
Hwang, J., Kim, J., Cha, M., Ryoo, I., Choo, S., Cho, S., Tsukumo, Y., Tomida, A., Shin‐ya, K., Hwang, Y., et al. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21308 · Cited by 43
Blouin, M., Zhao, Y., Zakikhani, M., Algire, C., Piura, E., & Pollak, M. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.08.021 · Cited by 32
Foster, R. R., Griffin, S., Grooby, S., Feltell, R. E., Christopherson, C., Chang, M., Sninsky, J. J., Kwok, S., & Torrance, C. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045061 · Cited by 16
Cited by
Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma
Feng, J., Li, J., Wu, L., Yu, Q., Ji, J., Wu, J., Dai, W., & Guo, C. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01629-4 · Cited by 699
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Shi, Q., Xue, C., Zeng, Y., Yuan, X., Chu, Q., Jiang, S., Wang, J., Zhang, Y., Zhu, D., & Li, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01828-x · Cited by 401
Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways
Jia, D., Lu, M., Jung, K. H., Park, J. H., Yu, L., Onuchic, J. N., Kaipparettu, B. A., & Levine, H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816391116 · Cited by 336
Kitamura, F., Semba, T., Yasuda-Yoshihara, N., Yamada, K., Nishimura, A., Yamasaki, J., Nagano, O., Yasuda, T., Yonemura, A., Tong, Y., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.163022 · Cited by 121
“Enhanced glycolysis in cancer cells, known as the Warburg effect, is a strategic metabolic adaptation by tumors to satisfy their increased requirements for energy to support continuous proliferation and leads to the development of a tumor-supportive microenvironment by altering metabolites (32, 33).”
BackgroundAllison, K. E., Coomber, B. L., & Bridle, B. W. (2017) · Immunology · doi:10.1111/imm.12777 · Cited by 109
Metadata
- Authors
- Bhattacharya, B., Mohd Omar, M. F., & Soong, R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2016-02-18
- Volume
- 173
- Issue
- 6
- Pages
- 970-979
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2224415831
- Cited by
- 298
- References
- 103
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.